No abstract available
Keywords:
multicentric Castleman disease; siltuximab.
Publication types
-
Clinical Trial, Phase II
-
Letter
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal / therapeutic use*
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use*
-
Castleman Disease / diagnosis
-
Castleman Disease / drug therapy*
-
Humans
-
Placebo Effect
-
Proportional Hazards Models
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal
-
Antineoplastic Agents
-
siltuximab
Supplementary concepts
-
Multi-centric Castleman's Disease